RE: Year End Results...To me 2010 wasn't a surprise. Everybody out there was aware that Egrifta will easily gain approval from FDA. From over a year now, TH announced that commercialisation deals were coming. We shoudn't expect SP to gap when there are going to sign the European deal in Q1 2011
To me the next catalyst will be the announcement of the PII results from both sponsored trials. Good results should put TH under the spotlights again. I think the trials are now completed, but don't know when they are going to announced the results. Probably H1 2011
We wanna hear something else than Lipodystrophy!